For both of these trials a measure of efficiency was also calculated for the receivers [no. of detections/100 (max no. of detections per minute x trial time)].
Surrogates are often biomarkers such as hemoglobin A1C [Hblood, blood pressure, lipid levels, etc. Surrogate outcomes are used in clinical trials for reasons of efficiency and practicality; they can be measured with fewer patients, less invasiveness and a shorter observation period [ 8].
By leveraging NLP and IE technologies, automated ES could dramatically increase the trial screening efficiency of oncologists and enable participation of small practices, which are often left out from trial enrollment.
By leveraging NLP and IE technologies on both the trial criteria and the EHR content of the patients, an automated eligibility pre-screening algorithm could dramatically increase the trial screening efficiency of oncologists.
At the end of the trial, feed efficiency (weight gain/feed intake), protein efficiency ratio (g of weight gain/g of protein fed), and specific growth rate values were computed, and three fish were collected from each tank for subsequent measurement of whole-body composition according to established procedures (Webb et al. 2003).
This paper reports the results of that randomized trial of the effectiveness and efficiency of home versus clinic delivered care for individuals with leg ulcers.
A few clinical phase I or II trials suggest a certain degree of efficiency of humanized or chimeric anti-CEA mAbs, radiolabeled with either Iodine or Ytrium, in heavily pre-treated patients with metastatic colorectal cancer (MCRC) CT84.66 [ 8, 14, 15].
Factorial trials maximise the efficiency of a trial by including more than one trial question into a single trial population.
Full tests of efficiency, however, require trials in integrated lines, currently in progress, and the usefulness of the technology could depend on the development of an improved repressible element.
Whereas adenoviral vectors are understood to exhibit superior levels of in vivo gene transfer compared to available alternative vector systems, their present level of efficiency in clinical trials may nonetheless be suboptimal for cancer gene therapy and virotherapy applications [ 2].
